Speaker Profile

Head of Oncology Informatics, Inspirata Inc.

Biography
Jesse is an experienced HIT sales leader, currently leading the Cancer Informatics team for Inspirata. He and his colleagues deliver high-caliber AI/NLP, Cancer Registry, and Clinical Trial Matching products, with a dedicated focus on improving patient outcomes. Prior to Inspirata, Jesse led a sales organization at Provation Medical, which is the industry-leading software organization for multidisciplinary clinical procedure documentation. He has helped several companies navigate through the shift from on-premises to SaaS-based business models while always focusing first on customer needs. When not at the office, Jesse is a passionate fly-fisherman, husband, and father of four beautiful girls.


Clinical & Research Tools Showcase:
Inspirata®, Inc.

Inspirata, Inc. helps patients fighting cancer—and the clinicians they trust—to make every moment matter. Our comprehensive cancer informatics solutions bring disparate data together throughout the entire cancer care journey to drive informed decisions that improve survivorship.

The Future of Clinical Trial Matching Is Digital
Inspirata has leveraged its expertise in oncology informatics and its industry-leading AI / NLP technology to create a clinical trial matching solution that truly addresses healthcare institutions’ needs. Come to our showcase to find out what makes Trial Navigator unique.

 Session Abstract – PMWC 2022 Silicon Valley

Track 6 - June 28 4.00 P.M.-4.15 P.M.,Track 6 - June 29 9.00 A.M.-1.15 P.M.,Track 6 - June 30 1.45 P.M.-2.00 P.M.


The PMWC 2022 Clinical & Research Tools Showcase will provide a 15-minute time slot for selected companies in this space. The Clinical & Research Tools is a showcase for innovative technologies that are used for the analysis of genetic variation and function, helping to advance breakthroughs in genetic health, rare disease conditions on individuals of all ages, complex diseases and cancer care. Next-generation sequencing (NGS) and microarray technologies empower rapidly evolving genomic revolution.